All News

$8.7 Million Awarded to Support Phase III Femoral Neck Fracture Trial by EU Horizon 2020 Program

HAIFA, Israel, Sept. 05, 2017 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that its Phase III study of PLX-PAD cells to support recovery following surgery for femoral neck fracture has been awarded an $8.7 million (7.4 million Euro) non-dilutive […]

NYIT biologist receives NIH support for bone-healing research

Public Release: 5-Sep-2017 NYIT (New York Institute of Technology) has been awarded $442,000 to pursue research into a gene critical in the formation and healing of bones. The United States’ National Institutes of Health (NIH) has awarded Life Sciences professor Michael Hadjiargyrou, Ph.D., a multi-year grant to study a newly discovered musculoskeletal […]

Mainstay Medical Announces Half Year Financial Results

September 05, 2017 Mainstay Medical International plc (Mainstay or the Company, Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain (CLBP), today announces the publication of its report […]

Medtronic Launches Long Term Clinical Study Program of INFUSE Bone Graft in Two Common Spine Procedures: PLF and TLIF

DUBLIN – September 5, 2017 – Medtronic plc (NYSE: MDT) today announced the launch of a long term clinical study program to collect prospective data on INFUSE® Bone Graft in Posterolateral Fusion (PLF) and Transforaminal Lumbar Interbody Fusion (TLIF) spine procedures. The first patient has been enrolled in the PLF study at […]

Implanet Presents Independent Radiological Results of the JAZZ Band at the SRS 52nd Annual Meeting & Course

September 05, 2017 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0010458729, PEA-PME eligible) (Paris:IMPL) (OTCQX:IMPZY), a medical technology company specializing in vertebral and knee-surgery implants, announces the publication of a White Paper entitled “How to optimize axial correction without altering thoracic sagittal alignment in hybrid constructs with […]

1st Patient Recruited in Orthocell Ortho-ATI® Shoulder Tendon Study

September 04, 2017 PERTH, Australia–(BUSINESS WIRE)–Regenerative medicine company Orthocell Limited (ASX:OCC) today announced that it has recruited and treated its first patient in a randomised, controlled clinical trial of Ortho-ATI® versus corticosteroid injection, for the treatment of rotator cuff tendinopathy and tear in the shoulder. Rotator cuff tendinopathy and tear […]

Mazor Robotics to Present at the Wells Fargo Healthcare Conference

September 05, 2017 CAESAREA, Israel–(BUSINESS WIRE)–Mazor Robotics Ltd. (TASE:MZOR)(NASDAQGM:MZOR), a pioneer and a leader in the field of surgical guidance systems announced today that Sharon Levita, Chief Financial Officer & Vice President, Business Operations, is scheduled to present an overview of the Company, via a fireside chat discussion, at the […]

Exactech To Present to Investors at Baird 2017 Global Healthcare Conference

September 05, 2017 GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, will present to investors at the Baird 2017 Global Healthcare Conference in New York on Thursday, September 7, 2017. The company will also host […]

EOS imaging Introduces Personalized Biomechanical Simulation in Spine Surgery Planning

September 05, 2017 PARIS–(BUSINESS WIRE)–EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced that it will introduce a new version of spineEOS, the Company’s online 3D planning software for spine surgery based on EOS stereo-radiographic 2D/3D imaging. spineEOS is the first software to incorporate […]

Bioventus Receives US FDA Approval for DUROLANE®

September 05, 2017 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, today announced it has received US FDA approval for DUROLANE, a single-injection, hyaluronic acid (HA) product used for joint lubrication in the treatment of pain associated with knee osteoarthritis (OA). Hyaluronic acid is a naturally occurring molecule that provides […]

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.4